1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Amgen Inc.
  6. News
  7. Summary
    AMGN   US0311621009

AMGEN INC.

(AMGN)
  Report
Delayed Nasdaq  -  05/23 04:00:00 pm EDT
249.04 USD   +0.62%
05/23WALL STREET STOCK EXCHANGE : Biden comments reassure investors
05/23SVB Securities Initiates Amgen at Market Perform With $256 Price Target
MT
05/23ANALYST RECOMMANDATIONS : AbbVie, Amgen, Caterpillar, HP, Nike...
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Amgen Plugs In: Electric Vehicle Pilot Program Advances Carbon Neutrality Goal

01/20/2022 | 11:41am EDT

Brent Meeks spends most of his workdays with Amgen behind the wheel of a car. As a senior specialty sales representative in Northern California, he visits physicians as much as two hours away from his home across a large rural territory that stretches from Yreka to Davis, California. When he received an email asking for volunteers to join a new electric vehicle pilot program for Amgen's field fleet, the self-described "car and technology nerd" jumped at the chance to take part.

"When Amgen announced last year that the company would become carbon neutral by 2027, my immediate thought was about the carbon footprint of the sales force and their vehicles," Meeks says. "I was excited to join the pilot program because I know electric vehicles are the future. Along with the sustainability benefits, they're fun to drive!"

Amgen's minimum 30% electrification target will significantly reduce carbon emissions

In the U.S., Amgen's field staff includes sales representatives and medical liaisons who drive long distances for business. Globally the field fleet represents around 15% of the company's overall carbon footprint, making the field fleet the third largest contributor of carbon emissions, only behind Amgen's two largest manufacturing facilities in Juncos, Puerto Rico, and Thousand Oaks, Calif.

"Adapting to cleaner technologies such as all-electric vehicles is critical," says Yanina Barrera, Ph.D., principal engineer, Engineering Technical Authority, who leads Amgen's sustainability efforts to increase electrification of the field fleet to at least 30%. "Although carbon is emitted to the atmosphere indirectly from charging, all-electric vehicles often provide the largest reductions in carbon emissions in comparison to conventional fossil fuel internal combustion engine vehicles in countries like the U.S., Netherlands, and South Korea."

For Jill Garand, senior specialty sales representative in the Anaheim territory of Southern California, getting in on the ground floor of this new program at Amgen was an easy choice. "This is the wave of the future. Where I live in California, you already see electric vehicles everywhere," she says. "Now that I drive an electric vehicle for work, it feels like I'm doing my part for the environment. Amgen is such a progressive company-this seems like a natural thing to do."

A better-and more sustainable-driving experience

Launching Amgen's electric vehicle pilot program in the U.S. was no easy task. It started by developing a cross-functional fleet team to address key challenges, including the lower mileage range of electric vehicles paired with limited charging infrastructure availability in some territories, the lack of available vehicles due to supply chain issues, and the need to recruit volunteers for the pilot program.

"To ensure business continuity, Amgen covered the cost of home charger installation so the field staff can charge their vehicles at home overnight," Barrera explains. "We also launched driver workshops to provide necessary information around common issues like public charging stations and reimbursement processes for electricity usage."

Both Meeks and Garand say that making the switch to their electric vehicles (both are driving the Volvo XC40 Recharge) was not only easy, but also that the experience of driving the cars has been fun, and they quickly noticed significant cost savings.

"By my calculations, I've figured that in the 9,000 miles I've driven the car, I've saved about 50% of what Amgen would be paying for gas for the same mileage, not to mention there's no oil changes or maintenance costs," Meeks says. "I also just look forward to driving the car. It's fun, it's high tech, and it puts a smile on my face every time."

"Even having to stop at a charging station for 30 minutes during the day became a positive change to my way of working," Garand says. "It gives me time to catch up on the administrative work that I used to end up doing in the evenings because I was always on the move during the day."

Pilot program is on the road and off to a strong start

The goal of Amgen's first electric vehicle pilot program is to capture lessons learned in preparation for launching a minimum of 1,800 electric vehicles on the road by 2027. "It will take global participation to help Amgen reach carbon neutrality by 2027," Barrera says, "and electrifying our fleet in countries that are ready is critical to making that happen."

As of January 1, 2022, Barrera's team has placed orders for 195 electric vehicles, which have been assigned to field staff, and that there are currently 105 Amgen field staff in the U.S. driving electric vehicles for work. Planning is also underway for deployment of all-electric vehicles in other geographies, including, but not limited to, the Netherlands and South Korea.

"Most importantly, this voluntary pilot program is empowering field staff to help us reach our carbon neutrality goal, and it's integrating a culture of environmental sustainability throughout our business," Barrera says. "I'd like thank my colleagues for the enormous efforts over the past year to help launch this program and achieving the 2021 environmental sustainability goal of 100 electric vehicles on the road in the midst of vehicle shortages and other global supply chain issues."

Learn more about Amgen's 2027 Environmental Sustainability Plan.

Disclaimer

Amgen Inc. published this content on 20 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 January 2022 16:40:00 UTC.


© Publicnow 2022
All news about AMGEN INC.
05/23WALL STREET STOCK EXCHANGE : Biden comments reassure investors
05/23SVB Securities Initiates Amgen at Market Perform With $256 Price Target
MT
05/23ANALYST RECOMMANDATIONS : AbbVie, Amgen, Caterpillar, HP, Nike...
05/18AMGEN INC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/16AMGEN INC. : Ex-dividend day for
FA
05/13Avantor Names Jonathan Peacock Chairman
MT
05/12Amgen and lance bass partner to encourage people to do a 'double take' to recognize the..
PR
05/12BridgeBio Inks BBP-398 License With Bristol Myers
DJ
05/11TRANSCRIPT : Amgen Inc. Presents at Bank of America 2022 Healthcare Conference, May-11-202..
CI
05/11INSIDER SELL : Amgen
MT
More news
Analyst Recommendations on AMGEN INC.
More recommendations
Financials (USD)
Sales 2022 26 226 M - -
Net income 2022 6 802 M - -
Net Debt 2022 26 905 M - -
P/E ratio 2022 19,7x
Yield 2022 3,05%
Capitalization 133 B 133 B -
EV / Sales 2022 6,10x
EV / Sales 2023 5,79x
Nbr of Employees 24 200
Free-Float 99,8%
Chart AMGEN INC.
Duration : Period :
Amgen Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AMGEN INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 28
Last Close Price 249,04 $
Average target price 246,97 $
Spread / Average Target -0,83%
EPS Revisions
Managers and Directors
Robert A. Bradway Chairman, President & Chief Executive Officer
Peter H. Griffith Chief Financial Officer & Executive Vice President
David M. Reese Senior VP-Translational Sciences & Oncology
Darryl Sleep Chief Medical Officer & Senior VP-Global Medical
Mike Zahigian Chief Information Officer & Senior Vice President
Sector and Competitors
1st jan.Capi. (M$)
AMGEN INC.10.70%133 037
JOHNSON & JOHNSON4.89%465 705
PFIZER, INC.-10.45%294 404
ELI LILLY AND COMPANY9.55%269 013
ABBVIE INC.9.33%266 851
ROCHE HOLDING AG-15.67%266 707